Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Canadian Medical Association Journal
|
March 3, 1979
Approach to drug therapy for hypertension
O G Kuchel, W A Mahon, J K McKenzie, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1973
Elimination of tritiated gentamicin in normal human subjects and in patients with severely impaired renal function
T W Wilson, W A Mahon, T Inaba, et al.
European Journal of Clinical Pharmacology
|
January 1, 1986
Pharmacokinetics of cimetidine after subchronic administration
T W Chin, M Spino, S M MacLeod, et al.
Scandinavian Journal of Infectious Diseases. Supplementum
|
January 1, 1976
The elimination of tritiated doxycycline in normal subjects and in patients with severely impaired renal function
W A Mahon, G E Johnson, L Endrenyl, et al.
Clinical Pharmacokinetics
|
August 1, 1987
Comparative bioavailability study of three sustained release quinidine formulations
W A Mahon, J S Leeder, M M Brill-Edwards, et al.
Therapeutic Drug Monitoring
|
January 1, 1980
Analysis of ranitidine in serum by high performance liquid chromatography
H M Vandenberghe, S M MacLeod, W A Mahon, et al.
Gastroenterology
|
September 1, 1985
Control of gastric pH with cimetidine: boluses versus primed infusions
M J Ostro, J A Russell, S J Soldin, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1981
Ranitidine kinetics and dynamics. I. Oral dose studies
P A Lebert, S M MacLeod, W A Mahon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 1995
Postanginal septicemia as a life-threatening complication of infectious mononucleosis
W L Gold, M K Kapral, M R Witmer, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1981
Ranitidine kinetics and dynamics. II. Intravenous dose studies and comparison with cimetidine
P A Lebert, W A Mahon, S M MacLeod, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Canadian Medical Association Journal
|
March 3, 1979
Approach to drug therapy for hypertension
O G Kuchel, W A Mahon, J K McKenzie, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1973
Elimination of tritiated gentamicin in normal human subjects and in patients with severely impaired renal function
T W Wilson, W A Mahon, T Inaba, et al.
European Journal of Clinical Pharmacology
|
January 1, 1986
Pharmacokinetics of cimetidine after subchronic administration
T W Chin, M Spino, S M MacLeod, et al.
Scandinavian Journal of Infectious Diseases. Supplementum
|
January 1, 1976
The elimination of tritiated doxycycline in normal subjects and in patients with severely impaired renal function
W A Mahon, G E Johnson, L Endrenyl, et al.
Clinical Pharmacokinetics
|
August 1, 1987
Comparative bioavailability study of three sustained release quinidine formulations
W A Mahon, J S Leeder, M M Brill-Edwards, et al.
Therapeutic Drug Monitoring
|
January 1, 1980
Analysis of ranitidine in serum by high performance liquid chromatography
H M Vandenberghe, S M MacLeod, W A Mahon, et al.
Gastroenterology
|
September 1, 1985
Control of gastric pH with cimetidine: boluses versus primed infusions
M J Ostro, J A Russell, S J Soldin, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1981
Ranitidine kinetics and dynamics. I. Oral dose studies
P A Lebert, S M MacLeod, W A Mahon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 1995
Postanginal septicemia as a life-threatening complication of infectious mononucleosis
W L Gold, M K Kapral, M R Witmer, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1981
Ranitidine kinetics and dynamics. II. Intravenous dose studies and comparison with cimetidine
P A Lebert, W A Mahon, S M MacLeod, et al.
Page
of 5